• A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
• A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
• A Novel Transmembrane CXCR4 Variant That Expands the WHIM Genotype-Phenotype Paradigm
• A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients
• Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
• An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid
• An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL
• An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL
• An Unusual Presentation of Propylthiouracil-Induced Immunoglobulin A Vasculitis With Positive Anti-proteinase-3 and Anti-myeloperoxidase Antibodies
• Assessing the Occurrence and Influence of Cancer Chemotherapy-Related Pharmacogenetic Alleles in the Chilean Population
• Autoimmune cytopenias in children: When to think of primary immunodeficiency?
• Autologous CD19- targeting CAR T cells in refractory juvenile dermatomyositis
• Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis
• AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001
• BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia
• Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
• Case Report of 11 Years of Severe Malabsorption, Muscular Atrophy, Seizures, and Immunodeficiency Resolved After Proximal Intercessory Prayer
• Case report of congenital neutropenia type 4 with glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency
• Case report: A case of novel homozygous LRBA variant induced by chromosomal segmental uniparental disomy - genetic and clinical insights
• Chronic disseminated candidiasis in a patient with acute leukemia - an illustrative case and brief review for clinicians
• Clinical and microbiological profile of Viridans group streptococcal bacteraemia; experience from South India
• Clinical Efficacy and Safety of Flumatinib in the Treatment of Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
• Clinical features and risk factors for invasive fungal sinusitis after allogeneic hematopoietic stem cell transplantation
• Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder
• Clinical impact of transient lymphopenia
• CMV Infection and Lymphopenia: Warning Markers of <em>Pneumocystis</em> Pneumonia in Kidney Transplant Recipients
• Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia
• Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis
• COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias
• COVID-19 in patients with Down syndrome: A systematic review
• COVID-19 Severity and Mortality in Veterans with Chronic Lung Disease
• CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
• CRISPR/Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
• CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies
• Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review
• Diagnostic guidance for hereditary neutropenia in children: Narrative literature review
• Discerning clinicopathological features of congenital neutropenia syndromes: an approach to diagnostically challenging differential diagnoses
• Down-Regulation of <em>INSR</em> Restores Th17/Treg Immune Balance and Alleviates Airway Hyperviscosity in Asthmatic Mice via Inactivation of STAT3 Pathway
• Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis
• Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia
• Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients
• Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey
• EXPRESS: Predictive Modeling of Mortality in Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections Using Machine Learning
• FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
• Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
• First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
• Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial
• From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis
• Genetic polymorphisms in IL-2, IL-10 and FOXP3 are associated with autoimmune neutropaenia in early childhood and autoantibody specificity in a Danish cohort
• Genetic polymorphisms in IL-2, IL-10 and FOXP3 are associated with autoimmune neutropenia in early childhood and autoantibody specificity in a Danish cohort
• Germline CEBPA Mutation as a Rare Cause of Chronic Neutropenia
• Immunophenotyping by spectral cytometry reveals a profile of lymphopenia associated with deregulation with an increase in effector memory lymphocytes in a patient with a mutation in the ITPR3 gene
• Inborn errors of immunity with susceptibility to <em>S. aureus</em> infections
• Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment
• Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
• Low-dose methotrexate toxicity leading to pancytopenia: leucovorin as a rescue treatment
• Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma
• Maribavir treatment for resistant cytomegalovirus disseminated disease in kidney transplant recipients: A case-based scoping review of real life data in literature
• Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia
• Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity
• Neutropenic Sepsis in the Intensive Care Unit: Differences in Clinical Profile and Outcomes According to the Cause of Neutropenia
• No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine-a prospective multicenter study by the Polish Adult Leukemia Group
• Open-Label Randomized Controlled Study of Ciprofloxacin vs Rifaximin as Neutropenia Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation
• Oral health management in children with severe congenital neutropenia with periodontitis: Case report
• Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients
• Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review
• Pathology and Clinics of Naturally Occurring Low-Virulence Variants of African Swine Fever Emerged in Domestic Pigs in the South Caucasus
• Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib
• Pattern and Predictors of Infection Among Patients With Rheumatological Disease on Immunosuppressive Medications: A Retrospective Study in a Tertiary Care Hospital in Bangladesh
• Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
• Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
• Predictive modeling of mortality in carbapenem-resistant <em>Acinetobacter baumannii</em> bloodstream infections using machine learning
• Presumed pseudo-Pelger-Huet anomaly and basophilia secondary to chronic lymphocytic leukemia in a dog
• Presumptive pulmonary toxocariasis in a patient affected by acute myeloid leukemia and Hodgkin lymphoma: case report and review of the literature in immunocompromised hosts
• Prevention and management of infectious complications in patients with chronic leucocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
• Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
• Primary Sjögren's syndrome without ocular manifestation: a case report
• Probiotic use in pediatric kidney transplant recipients: What are current practices, and are they evidence-based? A pediatric nephrology research consortium study
• Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis
• Real-World Efficacy and Safety of China-Made Flumatinib Mesylate in the Treatment of Chronic Myeloid Leukemia in Chronic Phase
• Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study
• Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia
• Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus
• Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit
• Risk factors for mortality in <em>Stenotrophomonas maltophilia</em> bacteremia - a meta-analysis
• Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer
• Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
• Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study
• Safety and efficacy of acalabrutinib and obinutuzumab in treatment-naive chronic lymphocytic leukemia: a Japanese phase 1 study
• Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study
• Safety of Docetaxel in a Patient with Metastatic Castration-Resistant Prostate Cancer After Kidney Transplantation: A Case Report
• Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database
• Sepsis Unveils T-cell Large Granular Lymphocytic Leukemia in the Setting of End-Stage Renal Disease: A Rare Hematologic Malignancy
• Serum interleukin-33 and soluble suppression of tumorigenicity 2 in pediatric leukemia with febrile neutropenia
• Streptococcal Esophagitis in an Immunocompetent Patient: A Rare Sequelae
• Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
• The Effect and Safety of Flumatinib in Patients with Chronic Myelogenous Leukemia Failed First-and Second-line Treatment
• The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS
• Tolerability of Daratumumab Amongst Asian Patients with Plasma Cell Dyscrasias - A Single Centre Experience
• Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management